Format

Send to

Choose Destination
Trends Immunol. 2005 Jun;26(6):318-25.

Inflammation-associated cancer: NF-kappaB is the lynchpin.

Author information

1
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. verma@salk.edu

Abstract

It has long been suspected that NF-kappaB signaling has a pivotal role in chronic inflammation-associated malignancies, although genetic evidence for this hypothesis has been lacking. However, recent papers have lent credence to this concept and show that NF-kappaB activation in pre-malignant cells contributes to cell survival and metastatic potential. Furthermore, NF-kappaB activation in tumor-associated leukocytes, especially macrophages, contributes towards tumorigenesis by upregulating tumor-promoting proinflammatory proteins. This emphasizes the importance of NF-kappaB inhibitors as immunotherapeutic agents for chronic inflammation and suggests that these reagents might prevent, or at least inhibit, chronic inflammation-associated tumorigenesis.

PMID:
15922948
DOI:
10.1016/j.it.2005.04.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center